Brett S Carver

6PUBLICATIONS
32CO-AUTHORS
Molecular targetsCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 26, 2025
ERG-driven prostate cancer initiation is cell-context dependent and requires KMT2A and DOT1L.

Weiran Feng, Erik Ladewig, Matthew Lange

|Feb 07, 2025
Uncoupling of Akt and mTOR signaling drives resistance to Akt inhibition in PTEN loss prostate cancers.

Ninghui Mao, Young Sun Lee, Nazifa Salsabeel

|Jul 19, 2024
Paclitaxel, Ifosfamide, and Cisplatin as Initial Salvage Chemotherapy for Germ Cell Tumors: Long-Term Follow-Up and Outcomes for Favorable- and Unfavorable-Risk Disease.

Jack P Gleeson, Andrea Knezevic, Maria Bromberg

|Aug 21, 2021
Defining the therapeutic selective dependencies for distinct subtypes of PI3K pathway-altered prostate cancers.

Ninghui Mao, Zeda Zhang, Young Sun Lee

Pageof 1